Gold (III) Derivatives in Colon Cancer Treatment
Cancer is one of the leading causes of morbidity and mortality worldwide. Colorectal cancer (CRC) is the third most frequently diagnosed cancer in men and the second in women. Standard patterns of antitumor therapy, including cisplatin, are ineffective due to their lack of specificity for tumor cell...
Main Authors: | Agata Gurba, Przemysław Taciak, Mariusz Sacharczuk, Izabela Młynarczuk-Biały, Magdalena Bujalska-Zadrożny, Jakub Fichna |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/2/724 |
Similar Items
-
Synthesis and Structural Characterization of Phosphanide Gold(III)/Gold(I) Complexes and Their Thallium(III) and Gold(III) Precursors
by: Laura Coconubo-Guio, et al.
Published: (2023-01-01) -
A New Gold(III) Complex, TGS 703, Shows Potent Anti-Inflammatory Activity in Colitis via the Enzymatic and Non-Enzymatic Antioxidant System—An In Vitro, In Silico, and In Vivo Study
by: Jakub Włodarczyk, et al.
Published: (2023-04-01) -
Organometallic gold(I) and gold(III) complexes for lung cancer treatment
by: Juzheng Zhang, et al.
Published: (2022-09-01) -
Gold nanoparticles: Synthesis properties and applications
by: Inès Hammami, et al.
Published: (2021-10-01) -
New Class of Anti-Inflammatory Therapeutics Based on Gold (III) Complexes in Intestinal Inflammation–Proof of Concept Based on In Vitro and In Vivo Studies
by: Julia B. Krajewska, et al.
Published: (2021-03-01)